Simon Dawson—Bloomberg/Getty Images
Company Information
As of 8/3/2022
Country
Britain
Headquarters
Brentford, Britain
Industry
Pharmaceuticals
CEO
Emma N. Walmsley
Website
Company Type
Public
Ticker
GSK
Revenues ($M)
$46,914.8
Profits ($M)
$6,030.4
Market Value ($M)
$87,095
Employees
90,096
Figures prepared in accordance with International Accounting Standards. Changed name from GlaxoSmithKline, May 16, 2022. Market value as of July 19, 2022.
Key Financials (Last Fiscal Year)As of 8/3/2022
($ Millions)
% change
Revenues ($M)
$46,914.8
7.3%
Profits ($M)
$6,030.4
-18.2%
Assets ($M)
$107,129.2
-
Total Stockholder Equity ($M)
$20,389
-
Profit RatiosAs of 8/3/2022
Profit as % of Revenues
12.9%
Profits as % of Assets
5.6%
Profits as % of Stockholder Equity
29.6%
GSK Rank History
Historical Data
Year | Revenues ($M) | Profits ($M) | Assets ($M) | Total Stockholder Equity ($M) |
---|---|---|---|---|
2021 | $43,731.81.5% | $7,373.124.4% | $109,949.2 | $19,940.4 |
2020 | $43,0734.8% | $5,927.422.7% | $105,552.1 | $15,105.9 |
2019 | $41,108.55.8% | $4,832.3145% | $73,941.2 | $5,552 |
2018 | $38,8683.3% | $1,972.660.3% | $76,252.4 | $-92 |
2017 | $37,6423% | $1,230.9-90.4% | $72,985 | $1,389 |
SHOW MORE
Lists ranking GSK
Latest news for GSK
- Health
CureVac scraps its first-generation COVID-19 vaccine candidate, shares tumbleOctober 12, 2021, 12:34 PM UTC - Leadership
GlaxoSmithKline gets rid of Trump’s vaccine adviser Slaoui for sexual harassmentMarch 24, 2021, 4:32 PM UTC